Nippon Sanso Holdings Corporation

All figures from Consolidated Financial Results (IFRS). EBITDA is defined as core operating income + depreciation & amortisation (this reproduces the company's 24.3% FYE2026 EBITDA margin).

Income statement

Diluted EPS equals basic: the company reports no dilutive shares.

Margins

Revenue CAGR FYE2022–FYE2026: 9.2% (analyst calculation). Excluding FX, growth is materially lower: the company quantified FX tailwinds to revenue of ~¥79.6bn (FYE2023), ~¥59.8bn (FYE2024) and ~¥22.9bn (FYE2026).

Non-recurring items (reconciliation of core to IFRS operating income)

The FYE2025 impairment (¥27.1bn total, of which ¥26.0bn related to the cancelled US hydrogen plant serving Vertex Energy's Mobile, Alabama renewable-diesel refinery) explains the FYE2025 dip in IFRS operating income and net income despite record core income.

Balance sheet

Adjusted net D/E per company = (net interest-bearing debt − equity-type debt) ÷ (equity attributable + equity-type debt); FYE2022 value derived from the company's stated 0.13-point improvement in FYE2023. Net debt above excludes lease liabilities (in "other financial liabilities").

Cash flow

Treasury-stock purchases were de minimis (¥5–18m per year; odd-lot purchases), so buybacks are effectively zero.

Ratios (analyst calculations unless stated)

Company-reported ROCE after tax for FYE2026: 7.1% (NS Vision 2026 KPI met). Our ROIC proxy (7.4%) differs because of definitional differences in capital employed.

Trend commentary

Revenue. The FYE2022–FYE2023 surge (+17%, +24%) was primarily nominal: energy-cost pass-through after the 2022 European energy shock and a sharp yen depreciation (USD from ¥113 to ¥136). From FYE2024 onwards, growth decelerated to 4–6% as energy surcharges normalised and volumes in air-separation gases declined in every year from FYE2023 to FYE2026 (company commentary). FYE2026 revenue growth of 3.9% included ~¥22.9bn FX tailwind and ~¥21.0bn from Coregas (nine months), implying underlying organic revenue was roughly flat — price up, volume down.

Profitability inflection. The key inflection came in FYE2024: core operating income jumped 34.8% to ¥166.0bn and core margin rose 280bp to 13.2% as pricing caught up with (and then outran) moderating energy costs. Margins have since expanded a further 170bp to 14.9%, and EBITDA margin reached 24.3% — still well below Linde (~29.8% adjusted operating margin) but now within reach of Air Liquide's 20.7% operating margin on an operating-income basis only if NSHD reaches its 17% FYE2030 target.

Below the line. Finance costs roughly doubled from ¥11.8bn to ¥25.7bn between FYE2022 and FYE2024 (higher USD/EUR rates on floating debt and refinancing of hybrids) before easing to ¥23.9bn. FYE2025 net income was depressed by the ¥26.0bn US hydrogen impairment; FYE2026 was clean, producing a 25.4% jump in net income.

Balance sheet repair. Equity ratio rose from 31.8% to 44.0%; adjusted net D/E fell from ~0.94x to 0.59x, beating the ≤0.7x KPI. Part of the equity growth is FX translation (+¥128bn in FYE2026 alone), so the improvement is partly currency-driven and reversible. Gross debt has been held near ¥850–900bn for five years while EBITDA rose 69%, which is the real deleveraging mechanism.

Cash generation. OCF rose 83% over four years. FCF stepped up to ¥163.4bn in FYE2026 as capex fell from a FYE2025 peak (¥146.8bn, which included spending on the cancelled hydrogen plant). FYE2026 was also the first year of meaningful M&A since 2019 (¥99.5bn, mainly Coregas), funded internally.

Goodwill concentration. Goodwill + intangibles of ¥961bn equal 79% of attributable equity — a structural legacy of the Praxair Europe and US acquisitions, and a latent impairment risk if European or US returns deteriorate.

Latest quarter — Q1 FYE2027 (April–June 2026)

Sources: FilingReader summary of Q1 filing (29 Jul 2026); Quartr event summary. Q1 FYE2027 operating income includes a ¥12.4bn gain on sale of the HQ land and ¥1.9bn impairment related to the HQ relocation. Japan segment income fell 9.7% to ¥12.1bn (lower electronics E&I sales); US, Europe and Asia & Oceania all grew revenue and segment income; Thermos revenue rose 5.5% to ¥9.1bn. Note: one aggregator (Quartr) reports Q1 net income as ¥44.7bn (+53%), which likely refers to net income including non-controlling interests; the attributable figure is ¥43.7bn.

Management guidance — FYE2027 (FX: ¥150/$, ¥175/€)

Q1 FYE2027 core operating income of ¥54.7bn equals 26.3% of the full-year guide (vs a mechanical 25%), and the street's pretax consensus (¥205bn) sits ~7% above guidance, suggesting management's numbers are conservative — particularly as Q1 FX was favourable.

Bull case

1. Margin runway is credible: core margin has expanded every year since FYE2023 (10.4% → 14.9%) and Q1 FYE2027 EBITDA margin reached 25.0%; the NI2030 ≥17% target requires ~50bp p.a., below the recent pace.

2. Cash compounding: FCF of ¥163bn in FYE2026 and guided ¥780bn of 4-year investment can be funded internally while deleveraging toward ≤1.5x net debt/EBITDA, supporting rerating.

3. Diversified growth vectors: ANZ (Coregas), Spain healthcare and electronics (Asia recovery, Tsukuba) offset Japan volume decline; A&O income +31% and Q1 US rebound show portfolio breadth.

Bear case

1. Price-led growth is maturing: volumes have fallen across the group; FYE2027 revenue guide is only +1.5%, and NI2030 implies just 2.5–3.7% revenue CAGR.

2. Returns stay sub-par: ROCE 7.1% vs Air Liquide 11.2% and Linde 24.2%; ¥961bn goodwill/intangibles and repeated impairments (US hydrogen ¥26bn; Philippines non-consolidated ¥8.7bn) cap value creation.

3. FX and governance overhangs: ~70% of revenue is overseas, so yen strength would reverse recent gains; MCG's ~50.5% control limits float, buybacks (none to date) and takeover optionality.

Catalysts and monitorables (next 12 months)

• H1 FYE2027 results (4 Nov 2026): US margin recovery under Alan Draper; Japan E&I trough.

• Any upward guidance revision (street pretax ~7% above guide).

• First NI2030 progress disclosures and capital-allocation execution (¥780bn).

• Mitsubishi Chemical's stance on its NSHD stake amid TSE parent-subsidiary listing reforms.

• Integrated Report 2026 (typically late September) — R&D, ESG metrics, ROCE by segment.

• Start-up of Las Vegas and Norway ASUs, India HyCO and US DAC oxygen projects (2026–27).

• FX: USD/JPY and EUR/JPY vs ¥150/¥175 assumptions.

• Semiconductor capex cycle in Japan/Asia and electronic-gas volumes.

Analyst verdict

Nippon Sanso Holdings has executed one of the more convincing self-help stories in the global industrial-gas sector. Over four years the group transformed from a leveraged, post-acquisition integrator with a 10% core margin into a 15% margin business generating ¥270bn of operating cash flow, cutting adjusted net D/E from ~0.94x to 0.59x and earning a JCR AA- rating. Europe — the Praxair legacy that once worried investors — is now the group's highest-margin and largest profit pool. All NS Vision 2026 targets were met, and the new Next Innovation 2030 plan is appropriately margin-centric rather than volume-dependent.

Yet the quality of growth is the central debate. Organic volumes have been declining, revenue growth has been carried by price and currency, and the forward plan implies only low-single-digit top-line growth. Capital returns remain mediocre — 7.1% ROCE versus double-digit returns at Air Liquide and Linde — and the balance sheet still carries ¥961bn of goodwill and intangibles. The FYE2025 hydrogen write-off also demonstrates that diversification into energy-transition projects carries real execution risk. Finally, Mitsubishi Chemical's majority stake constrains capital-return flexibility (no buybacks) and keeps a governance discount embedded in the valuation.

At ~18x forward earnings and ~9x EV/EBITDA, the shares price in continued margin expansion but not a step-change in returns. The stock looks reasonably valued with moderate upside if management delivers its ≥17% margin and ≥8% ROCE targets and if the new CEO, Tadaharu Watanabe, fixes US profitability. The most important swing factor over 12 months is likely US margin recovery, followed by the electronics cycle and the yen. A structural rerating likely requires either a clearer return on the ¥780bn investment programme or resolution of the parent-subsidiary structure. Net assessment: fundamentally improving, balance-sheet strong, valuation fair; a "quality-at-reasonable-price" holding with execution and governance as key watchpoints.

---

APPENDIX — SOURCES

Primary (company):

• Consolidated Financial Results for FYE2026 (11 May 2026): https://jp.nipponsanso.com/en/LinkClick.aspx?fileticket=SrL2KGfyPlg%3d&tabid=196&mid=797

• Consolidated Financial Results for FYE2024 (13 May 2024): https://jp.nipponsanso.com/en/LinkClick.aspx?fileticket=wZvSfwc7zD0%3d&tabid=196&mid=797

• Consolidated Financial Results for FYE2023 (11 May 2023): https://jp.nipponsanso.com/en/LinkClick.aspx?fileticket=Tc4ksNWF5qg%3d&tabid=196&mid=797

• Announcement of MTP "Next Innovation 2030" (24 Mar 2026): https://jp.nipponsanso.com/en/LinkClick.aspx?fileticket=HCjIT22iv1Q%3d&tabid=210&mid=797

• IR top page / IR calendar: https://jp.nipponsanso.com/en/ir/

• Quarterly results index: https://jp.nipponsanso.com/en/ir/financial/financial_results.html

• Medium-term plan page: https://jp.nipponsanso.com/en/ir/management/plan.html

• FYE2026 earnings presentation (TDnet mirror): https://finance-frontend-pc-dist.west.edge.storage-yahoo.jp/disclosure/20260511/20260511522285.pdf

Credit:

• JCR rating list and releases: https://jcr.co.jp/en/ratinglist/corp/4091 ; https://jcr.co.jp/download/ad52f9d345a92f7dea2d5adcfed794f5a8665058205ad5bbf6/26d0087_f.pdf

Filings summaries / news:

• FilingReader (MTP, Q1 FYE2027, impairments): https://filingreader.com/news-wire/tokyo/2026-05-22/nippon-sanso-targets-jpy-1575tn-revenue-in-2030-plan ; https://filingreader.com/news-wire/tokyo/2026-07-29/taiyo-nippon-sanso-reports-strong-first-quarter-profit-growth ; https://filingreader.com/news-wire/tokyo/2026-05-11/nippon-sanso-to-record-87bn-yen-impairment-loss ; https://filingreader.com/news-wire/tokyo/2025-03-25/taiyo-nippon-sanso-records-impairment-loss-revises-earnings-forecast ; https://filingreader.com/news-wire/tokyo/2025-10-30/nippon-sanso-holdings-boosts-dividend-reports-strong-half-year-performance

• Quartr Q1 FYE2027 summary: https://quartr.com/events/nippon-sanso-holdings-corporation-4091-q1-2027_F4oXPfwv

• gasworld: https://www.gasworld.com/story/nippon-sanso-reports-159m-jump-in-full-year-profit/2249182.article/ ; https://www.gasworld.com/story/nippon-sanso-reports-strong-q1-growth-as-electronics-gases-and-pricing-boost-earnings/2255744.article/ ; https://gasworld.com/story/nippon-sanso-cancels-us-hydrogen-project-and-announces-190m-write-down/2153518.article ; https://gasworld.com/story/nippon-gases-partners-with-polaris-to-bolster-engineering-expertise/2146081.article ; https://www.gasworld.com/story/nippon-sanso-deepens-hysytech-partnership-through-investment/2253492.article/

• Gas Review (gasmos): https://gasmos.gasreview.co.jp/column/1040 ; https://gasmos.gasreview.co.jp/column/nippon-sanso-holdingsnippon-sanso-holdings-posts-extraordinary-loss-of-26-billion-in-fy25-related-to-low-carbon-businessnippon-sanso-holdings

• Businesswire (Draper; brand unification): https://www.businesswire.com/news/home/20260410619941/en/ ; https://www.businesswire.com/news/home/20250828187584/de

• hydronews (HYSYTECH): https://www.hydronews.it/en/biofuels-biogas-and-hydrogen-japans-nippon-sanso-invests-in-hysytech/?amp=1

• Leaders League (AGN Energia): https://www.leadersleague.com/de/news/agn-energia-sells-technical-gas-business-to-nippon-gases

• MarketScreener (guidance revision; valuation): https://www.marketscreener.com/news/nippon-sanso-holdings-corporation-revises-earnings-guidance-for-the-fiscal-year-ending-march-31-202-ce7e5adad18bf223 ; https://in.marketscreener.com/quote/stock/NIPPON-SANSO-HOLDINGS-COR-6491962/

History / profiles / market data:

• the-shashi (corporate history; CEO profile): https://the-shashi.com/en/tse/4091/ ; https://the-shashi.com/tse/4091/executives/ceo/watanabe-tadaharu/

• Wikipedia: https://en.wikipedia.org/wiki/Nippon_Sanso_Holdings_Corporation

• Chemistry World / Legal Business (2014 tender): https://chemistryworld.com/news/mitsubishi-to-buy-japanese-gases-specialist/7804.article ; https://legalbusinessonline.com/node/65404

• theofficialboard (CEO change): https://www.theofficialboard.com/news/nippon-sanso-holdings

• Simply Wall St (management/compensation): https://simplywall.st/stocks/jp/materials/tse-4091/nippon-sanso-holdings-shares/management

• TipRanks (statistics, employees): https://www.tipranks.com/stocks/jp:4091/statistics

• kabuyoho (consensus, price): https://kabuyoho.jp/reportTarget?bcode=4091 ; https://kabuyoho.jp/reportDps?bcode=4091

• traders.co.jp / Matsui (price data): https://www.traders.co.jp/stocks/4091/ ; https://finance.matsui.co.jp/stock/4091/index

• envalith (company overview): https://envalith.com/en/companies/4091/overview

Peers:

• Linde FY2025 results: https://www.businesswire.com/news/home/20260205319632/en/Linde-Reports-Full-Year-and-Fourth-Quarter-2025-Results

• Air Liquide FY2025 results: https://airliquide.com/group/press-releases-news/2026-02-20/2025-record-performance-and-confident-its-transformation-dynamic-air-liquide-confirms-its-growth